Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Colon/Rectum Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00032110
What this trial is testing

Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+3 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT00967616
What this trial is testing

Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy

Who this might be right for
Colorectal CancerNeoplasms, Colorectal
Daiichi Sankyo 100
Not applicableEnded earlyNCT03328065
What this trial is testing

Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum, Pancreas or Lung, or Gastrointestinal Neuroendocrine Tumours

Who this might be right for
Non-resectable Metastatic Cancer of the LungNon-resectable Metastatic Cancer of the ColonNon-resectable Metastatic Cancer of the Rectosigmoid Junction+5 more
Centre Hospitalier Universitaire Dijon
Testing effectiveness (Phase 2)UnknownNCT03225937
What this trial is testing

Evaluation of Trastuzumab in Combination With Lapatinib or Pertuzumab in Combination With Trastuzumab-Emtansine to Treat Patients With HER2-positive Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Fondazione del Piemonte per l'Oncologia 54
Testing effectiveness (Phase 2)Study completedNCT00752570
What this trial is testing

A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma

Who this might be right for
CancerCarcinomaColon Cancer+7 more
Amgen 144
Large-scale testing (Phase 3)Ended earlyNCT01189227
What this trial is testing

Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery

Who this might be right for
Colorectal CancerMetastatic Cancer
NSABP Foundation Inc 9
Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Testing effectiveness (Phase 2)Study completedNCT00003103
What this trial is testing

Chemotherapy in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Memorial Sloan Kettering Cancer Center 57
Post-approval studies (Phase 4)Ended earlyNCT00216424
What this trial is testing

Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma

Who this might be right for
Colorectal Cancer
James A. Haley Veterans Administration Hospital 40
Not applicableActive Not RecruitingNCT05038254
What this trial is testing

Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events

Who this might be right for
Clinical Stage IV Esophageal Adenocarcinoma AJCC v8Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage IV Gastric Cancer AJCC v8+42 more
M.D. Anderson Cancer Center 750
Testing effectiveness (Phase 2)Study completedNCT00003446
What this trial is testing

Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Grupo Oncologico Cooperativo del Sur
Early research (Phase 1)Study completedNCT04164069
What this trial is testing

Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab

Who this might be right for
Advanced Colorectal CarcinomaMetastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8+13 more
Anne Noonan 9
Not applicableActive Not RecruitingNCT07448662
What this trial is testing

Local Treatment Strategies for Brain Metastases of Colorectal Cancer

Who this might be right for
Colorectal CancerBrain Metastases, Adult
Blokhin's Russian Cancer Research Center 700
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Not applicableStudy completedNCT06083974
What this trial is testing

Metastatic Left Colon and Rectal Cancer Treatment With Anti_EGFR Targeted Therapy

Who this might be right for
Metastatic Colorectal Adenocarcinoma
Assiut University 100
Not applicableStudy completedNCT00040820
What this trial is testing

Oxaliplatin in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Roswell Park Cancer Institute
Early research (Phase 1)Study completedNCT01380600
What this trial is testing

Phase 1b Dose Escalation Study of Intravenous JX-594 in Metastatic, Refractory Colorectal Carcinoma

Who this might be right for
Carcinoma, Colorectal
Jennerex Biotherapeutics 15
Testing effectiveness (Phase 2)WithdrawnNCT02575508
What this trial is testing

Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer

Who this might be right for
Colon AdenocarcinomaMetastatic Pancreatic AdenocarcinomaPancreatic Adenocarcinoma+14 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT01802320
What this trial is testing

Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery

Who this might be right for
Colon Mucinous AdenocarcinomaColon Signet Ring Cell AdenocarcinomaRectal Mucinous Adenocarcinoma+13 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Study completedNCT00089635
What this trial is testing

Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerMetastases
Amgen 203
Next Page
36